Advertisement
Screener

CVS HEALTH CORPORATION (CVS) Material Contracts, 2020

CVS HEALTH CORPORATION Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2020-11-06: Form 10-Q; Exhibit 10.1; Description Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant..
  • 2020-08-05: Form 10-Q; Exhibit 10.1; Description 364-Day Credit Agreement dated as of May 13, 2020 by and among the Registrant, the lenders party thereto, Barclays Bank PLC and JPMorgan Chase Bank, N.A., as Co-Syndication Agents, Goldman Sachs Bank USA, and Wells Fargo Bank, National Association, as Co-Documentation Agents, and the Bank of America, N.A., as Administrative Agent..
  • 2020-05-06: Form 10-Q; Exhibit 10.1; Description Separation Agreement dated March 3, 2020 between CVS Pharmacy, Inc. and Derica W. Rice..
  • 2020-02-18: Form 10-K; Exhibit 10.56; Description Restrictive Covenant Agreement dated July 8, 2019 between the Registrant and Thomas Moriarty..
FiledFormExhibitDescription
2020-11-0610-Q10.1Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant.
2020-08-0510-Q10.1364-Day Credit Agreement dated as of May 13, 2020 by and among the Registrant, the lenders party thereto, Barclays Bank PLC and JPMorgan Chase Bank, N.A., as Co-Syndication Agents, Goldman Sachs Bank USA, and Wells Fargo Bank, National Association, as Co-Documentation Agents, and the Bank of America, N.A., as Administrative Agent.
2020-05-0610-Q10.1Separation Agreement dated March 3, 2020 between CVS Pharmacy, Inc. and Derica W. Rice.
2020-02-1810-K10.56Restrictive Covenant Agreement dated July 8, 2019 between the Registrant and Thomas Moriarty.
2020-02-1810-K10.54Restrictive Covenant Agreement dated June 19, 2019 between the Registrant and Derica Rice.
2020-02-1810-K10.48Restrictive Covenant Agreement dated June 21, 2019 between the Registrant and Eva Boratto.
2020-02-1810-K10.27The Registrant’s Management Incentive Plan.
2020-02-1810-K10.14The Registrant’s Deferred Compensation Plan, as amended and restated.
2020-02-1810-K10.11The Registrant’s Deferred Stock Compensation Plan, as amended and restated.

Similar stocks

Stock NameCountryMarket CapPE Ratio
PETMED EXPRESS INC (PETS)United States$0.034B-1.41